Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases
Valverde Romero E.D., Parras Padilla T., Herrero Hernández A., Pérez Grande R., Fernández Vázquez M., García García M.I., et al. Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases. Diagn Microbiol Infect Dis 59 (2007) 433-437
Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Document M100-S16. Wayne, PA: CLSI; 2006.
Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Document M100-S16. Wayne, PA: CLSI; 2006.
4
46249122640
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan
Liu C.Y., Huang Y.T., Liao C.H., and Hsueh P.R. In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan. Antimicrob Agents Chemother 52 (2008) 2677-2679
Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England
Hope R., Warner M., Potz N.A.C., Fagan E.J., James D., and Livermore D.M. Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England. J Antimicrob Chemother 58 (2006) 1312-1314
Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline
Morosini M.I., García-Castillo M., Coque T.M., Valverde A., Novais A., Loza E., et al. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob Agents Chemother 50 (2006) 2695-2699